Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Hazard for aquatic organisms

Hazard for air

Hazard for terrestrial organisms

Hazard for predators

Additional information

Conclusion on classification

3,4-xylenol has a harmonised environmental classification of Aq. Chronic 2. At the time of assessing the harmonised classification (according to the former legislation, years before the CLP Regulation came into force), only data on fish (Pimephales promelas) and aquatic invertebrates (Daphnia magna and Crangon septemspinosa) were available for 3,4-xylenol.


 


- Short-term (acute) aquatic hazard:


LC50 fish (P. promelas): 14 mg/L


EC50 aquatic invertebrates (D. magna): 3.36 mg/L (NOACK, 2021) and  18.7 mg/L (Ecetox, 2019)


EC50 aquatic invertebrates (C. septemspinosa): 13.7 mg/L


ErC50 algae: 9.32 mg/L


No classification for Aq. Acute 1 is warranted. The LC50 for fish, EC50 for crustacea and ErC50 for algae are all > 1 mg/l.


 


- Long-term (chronic) aquatic hazard:


chronic toxicity data:


NOEC algae: 1.58 mg/L (based on growth rate inhibition)


acute toxicity data:


LC50 fish (P. promelas): 14 mg/L


EC50 aquatic invertebrates (D. magna): 3.36 mg/L (NOACK, 2021) and 18.7 mg/L (Ecetox, 2019)


EC50 aquatic invertebrates (C. septemspinosa): 13.7 mg/L


3,4-xylenol is predicted to be not readily biodegradable. Based on this prediction and the observed aquatic toxicity, an Aq. Chronic 2 classification is warranted (surrogate method: derivation of a chronic classification on the basis of an acute Ecotoxicity Reference value of 3.36 mg/L). This self-classification is in line with the Harmonised Classification as reported in Annex VI of the CLP-Regulation.